What is Zentalis Pharmaceuticals, Inc. Common Stock's Market Cap?

Zentalis Pharmaceuticals, Inc. Common Stock's Market Cap is $288.8M, based on as-reported figures from SEC (XBRL) filings.

What is Zentalis Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Zentalis Pharmaceuticals, Inc. Common Stock's Enterprise Value is $264.1M, based on as-reported figures from SEC (XBRL) filings.

What is Zentalis Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Zentalis Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Zentalis Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Zentalis Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Zentalis Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Zentalis Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$139.5M, based on as-reported figures from SEC (XBRL) filings.

What is Zentalis Pharmaceuticals, Inc. Common Stock's EBITDA?

Zentalis Pharmaceuticals, Inc. Common Stock's EBITDA is -$152.8M, based on as-reported figures from SEC (XBRL) filings.

What is Zentalis Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Zentalis Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.95, based on as-reported figures from SEC (XBRL) filings.

What is Zentalis Pharmaceuticals, Inc. Common Stock's Net Debt?

Zentalis Pharmaceuticals, Inc. Common Stock's Net Debt is -$24.8M, based on as-reported figures from SEC (XBRL) filings.

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) Financial Statements

Zentalis Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00R2K8TG4

XNAS · usd

4.03▲ 0.04 (1.00%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.99

Day's Range3.89 – 4.10

52-Week Range1.21 – 6.85

Volume518.7K

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees106

ExchangeXNAS

Listed2020-04-03

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL)

What is Zentalis Pharmaceuticals, Inc. Common Stock's Market Cap?: Zentalis Pharmaceuticals, Inc. Common Stock's Market Cap is $288.8M, based on as-reported figures from SEC (XBRL) filings.
What is Zentalis Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Zentalis Pharmaceuticals, Inc. Common Stock's Enterprise Value is $264.1M, based on as-reported figures from SEC (XBRL) filings.
What is Zentalis Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Zentalis Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Zentalis Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Zentalis Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Zentalis Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Zentalis Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$139.5M, based on as-reported figures from SEC (XBRL) filings.
What is Zentalis Pharmaceuticals, Inc. Common Stock's EBITDA?: Zentalis Pharmaceuticals, Inc. Common Stock's EBITDA is -$152.8M, based on as-reported figures from SEC (XBRL) filings.
What is Zentalis Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Zentalis Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -1.95, based on as-reported figures from SEC (XBRL) filings.
What is Zentalis Pharmaceuticals, Inc. Common Stock's Net Debt?: Zentalis Pharmaceuticals, Inc. Common Stock's Net Debt is -$24.8M, based on as-reported figures from SEC (XBRL) filings.